Trials / Completed
CompletedNCT06428214
A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies
A Post-market, Open-label, 3-Armed, Parallel Group, Multicenter Study to Evaluate Aesthetic Improvement and Safety of Restylane Shaype for Temporary Augmentation of the Chin Region Alone or in Combination With Restylane Defyne and Restylane Lyft Lidocaine Treatment in the Lower Face and Midface
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study's main purpose is to evaluate the overall aesthetic improvement of the treated areas by treatment group, as assessed by the Investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Shaype | Injection |
| DEVICE | Restylane Defyne | Injection |
| DEVICE | Restylane Lyft lidocaine | Injection |
Timeline
- Start date
- 2024-05-13
- Primary completion
- 2024-07-25
- Completion
- 2024-09-24
- First posted
- 2024-05-24
- Last updated
- 2025-01-31
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT06428214. Inclusion in this directory is not an endorsement.